Business Wire

LLPA

Share
Digital Transformation is About People! Registrations Officially Open for the Biggest C3 Global Cloud Skills Event, Powered by the Leading Learning Partners Association

The Leading Learning Partners Association (LLPA), an international association of 32 members across 55+ countries, have successfully hosted a series of C3 cloud skills tour events in over 17 countries in a virtual setting since January 2021.

We recognize that transformation to cloud technologies requires skills transformation and most importantly, that digital transformation is about people. During this event, The LLPA in close cooperation with Microsoft and other key partners provide business leaders, executives, IT professionals, developers and Microsoft Azure consultants, an opportunity to gain valuable insights and learn from local and international leading industry experts on topics such as building high-performance teams and better ways of leveraging existing and future cloud investments. This exciting global tour is famous for bringing learning thought leaders, executives, and partners, together to collaborate and share best practices.

“Leading transformation starts with an idea, a vision and the ability to identify expectations. For this you must be informed, knowledgeable, and equipped. The sphere of cloud technology is robust and ever changing. We’re inviting IT professionals and leaders everywhere, to attend the final C3 Global Cloud Skills Tour event to gain knowledge from leading experts that will help organizations of all sizes build a future-ready workforce” says Patrick Kersten, Chairman of the Board at LLPA.

“Contrary to popular belief, digital transformation is less about technology and more about people. You can pretty much buy any technology, but your ability to adapt to an even more digital future depends on developing the next generation of skills, closing the gap between talent supply and demand, and future-proofing your own and others’ potential” – Harvard Business Review. The C3 Global Cloud Skills Tour aims to address the cloud skills gaps by ensuring all existing and future cloud customers have the technical and soft skills needed to be successful.

The LLPA will host this live 2-day event 9-10 June 2021 from 9-1pm CET joined by international speakers, Ken Taylor , President – Training Industry, Inc., Kåre Nygård , Head of Digital Consulting Norway – TietoEVRY, Mohanna Azarmandi , Chief Learning Officer – Microsoft, Jayne Groll , CEO – DevOps Institute and many others. The LLPA have more than 15 live and on-demand sessions planned, ranging from technical deep dives to digital transformation and skilling best practice sessions. We also have a great panel discussion lined up led by leading training providers from multiple regions.

“We need to adjust and embrace a more virtual way of living and more than ever it is vital that people remain closely connected. It is great to see that the global network of the Leading Learning Partner Association is showing leadership to deliver 100% virtual trainings to support our mutual customers in the continuation and acceleration of their skilling efforts to support their digital transformation strategy. These efforts have been recognized by our mutual customers and Microsoft awarded the Leading Learning Partners Association with a global Learning Partner of the year award, for their continuous commitment for accelerating cloud skills.” – Geoff Hirsch, Senior Director of Partner Channel, WW Learning & Readiness at Microsoft.

About The LLPA

Born in the Netherlands in 2013, the Leading Learning Partners Association (LLPA) is a global organization with a member presence in more than 55 countries. Our mission is to be THE global cloud skills services organization, dedicated to providing the right tools, learning resources and services at the right time to ensure cloud skills are accessible to anyone and everyone at any time across the globe.

Our extensive network of trusted members contributes to the development of expert job-ready industry professionals through hybrid learning offerings, consulting, and certification. Together, our members have trained over 500,000 students per year, covering more than 90% of the European GDP. The LLPA has been a Microsoft Partner since 2013 and awarded Microsoft Learning Partner of the Year 2020.

Link:

ClickThru

Social Media:

https://www.facebook.com/theLLPA/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TRU Simulation’s Bell 525 Flight Simulator Receives FAA Interim Level C Qualification17.11.2025 09:00:00 CET | Press release

TRU Simulation + Training Inc., a Textron Inc. (NYSE:TXT) company, and an affiliate of Textron Aviation Inc. and Bell Textron Inc. today announced its Bell 525 Full Flight Simulator (FFS) located at the Bell Training Academy received Interim Level C qualification from the Federal Aviation Administration (FAA). Bell Textron Inc. has designed and will manufacture the Bell 525 helicopter. By achieving this milestone, pilots can earn more flight hours on the Bell 525 platform ahead of the rotorcraft’s expected FAA type certification. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117520706/en/ TRU Simulation’s Bell 525 Flight Simulator receives FAA Interim Level C qualification “The accuracy and realism of our Flight Simulation Devices play a crucial role in ensuring that pilots can effectively translate their training into real-world scenarios,” said Jerry Messaris, vice president and general manager, TRU Simulation. “This q

Polpharma Biologics Confirms U.S. Launch of Tyruko® (natalizumab), the First and Only Biosimilar for Multiple Sclerosis17.11.2025 08:52:00 CET | Press release

Polpharma Biologics, a biopharmaceutical company group focused on biosimilars development and manufacturing, today confirmed that Sandoz Tyruko® (natalizumab-sztn) is now available to patients in the United States. Tyruko® is the first and only FDA-approved biosimilar of natalizumab for the treatment of relapsing forms of multiple sclerosis (MS), and also for adult patients with moderately to severely active Crohn’s disease1. Tyruko® was developed by Polpharma Biologics and will be commercialized in the U.S. by its collaboration partner Sandoz, under an exclusive global license agreement. The launch marks a significant milestone in expanding access to high-quality, affordable treatment options for patients living with MS and Crohn’s disease in the United States. Emmanuelle Lepine, Chair of the Supervisory Board, Polpharma Biologics, commented: "The U.S. launch of Tyruko® marks a pivotal moment not only for Polpharma Biologics, but for patients across the United States. This milestone r

Lone Star Acquires Multi-Asset Real Estate Portfolio from St. James’s Place17.11.2025 08:01:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has successfully completed the acquisition of a multi-asset real estate portfolio from St. James’s Place (SJP) and its Property Unit Trust and Life and Pensions Trust. SJP was advised by Invesco Real Estate, the global real estate investment manager, on the sale of the portfolio. The portfolio comprises 16 high-quality assets across the UK, including multi-let industrial (“MLI”), retail, and office properties. The largest component is the MLI portfolio, which consists of 10 separate property assets predominantly located in Greater London and South East England, and offering access to major transportation and industrial hubs — making them highly attractive for last-mile delivery and regional distribution. The office properties are all situated in London, while the retail assets consist of high-quality retail warehouses with strong tenant bases. Lone Star will implement an active asset

Bureau Veritas appoints Santiago Arias Duval as Executive Vice-President for the Americas region17.11.2025 08:00:00 CET | Press release

Bureau Veritas, a global leader in Testing, Inspection and Certification (TIC), is pleased to announce the appointment of Santiago Arias Duval, effective November 17th, 2025, as Executive Vice-President, Americas. This appointment is in line with Bureau Veritas’ new operating model effective since September 1st, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251116192035/en/ Hinda Gharbi, CEO at Bureau Veritas Bureau Veritas is evolving the structure of its executive committee to drive greater organizational alignment. This organization will empower the regions with scalable Product Lines, enabling global solutions development, and will be unlocking wider cross-selling opportunities. The Americas region is created to leverage fast developing market opportunities across countries in North, Central and South America. This is a dynamic region for all Bureau Veritas where the group intends to expand its leadership across p

Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)17.11.2025 07:00:00 CET | Press release

Pending the European Commission decision, Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide will represent an important new therapeutic option from second line for patients with follicular lymphoma (FL) in EuropeIn Western countries, relapsed or refractory FL affects 2-4 out of every 100,000 people1The positive Committee for Medicinal Products for Human Use (CHMP) recommendation is based on data from the Phase 3 inMIND trial which showed patients with relapsed or refractory FL achieved significantly improved progression-free survival with Minjuvi in combination with rituximab and lenalidomide2 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) (Grade 1-3a) after at

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye